Ludwig Enterprises (LUDG) Amortization of Deferred Charges (2023 - 2024)
Ludwig Enterprises (LUDG) posted Amortization of Deferred Charges of $106800.0 for Q4 2024, down 71.73% on a QoQ basis from $377774.0 in Q3 2024, and down 53.25% year-over-year from $228437.0 in Q1 2024.
Ludwig Enterprises (LUDG) Amortization of Deferred Charges (2023 - 2024) Analysis & Trends
Ludwig Enterprises' Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at $106800.0 for Q4 2024.
- Quarterly Amortization of Deferred Charges fell 53.25% year-over-year to $106800.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $899171.0 (changed N/A YoY) and the FY2024 annual result came in at $1.0 million, up 94.14% from the prior year.
- Amortization of Deferred Charges was $106800.0 for Q4 2024 at Ludwig Enterprises, down from $377774.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $377774.0 in Q3 2024 and bottomed at $106800.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.64 Bn | 176.34 Bn | 6.27 Bn |
| 2 | Stryker | 129.04 Bn | 126.16 Bn | 3.81 Bn |
| 3 | Medtronic | 109.04 Bn | 99.82 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.67 Bn | 45.00 Bn | 1.29 Bn |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.34 Bn | - |
| 9 | Koninklijke Philips | 25.48 Bn | 22.36 Bn | 2.07 Bn |
| 10 | Ludwig Enterprises | 3.27 Mn | 3.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 106,800.00 |
| Dec 31, 2024 | 106,800.00 |
| Sep 30, 2024 | 377,774.00 |
| Sep 30, 2024 | 377,774.00 |
| Dec 31, 2023 | 228,437.00 |
| Dec 31, 2023 | 228,437.00 |
| Sep 30, 2023 | 186,160.00 |
| Sep 30, 2023 | 186,160.00 |